Physician profile
Ashwin Rao
NPI 1639673106
$1,927.49
in general payments reported to CMS, 2019-2025
15 companies · $271 in 2025
The $271 reported for 2025 was more than what 82% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $437 · 2023: $489 · 2024: $730 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,490.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $552.65 | 2023-2025 | Stelara, Tremfya |
| Abbvie INC. | $503.70 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $207.36 | 2022-2025 | Entyvio, Eohilia |
| Gilead Sciences, INC. | $150.98 | 2022-2023 | Epclusa |
| Janssen Scientific Affairs, LLC | $90.72 | 2023 | Remicade, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $85.65 | 2022-2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $72.66 | 2023-2024 | Dificid |
| Medtronic, INC. | $71.43 | 2023 | Pillcam |
| Qol Medical, LLC | $45.76 | 2022-2023 | Sucraid |
| Regeneron Healthcare Solutions, INC. | $34.04 | 2024 | Dupixent |
| Boston Scientific Corporation | $33.93 | 2025 | Orise, Overstitch Endoscopic Suturing System |
| Conmed Corporation | $31.10 | 2022 | |
| Stryker Corporation | $18.67 | 2023 | Photonsaber Y, Eikon Lt Adapt Smoke Evacuation, Photonblade |
| Intercept Pharmaceuticals, INC. | $15.39 | 2024 | |
| Ipsen Biopharmaceuticals, INC | $13.45 | 2024 | Iqirvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashwin Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.